Iterum Therapeutics plc
ITRM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $11 | $13 | $13 | $24 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $1 | $0 | $0 | $0 |
| Inventory | $1 | $1 | $1 | $0 |
| Other Curr. Assets | $1 | $1 | $0 | $1 |
| Total Curr. Assets | $14 | $15 | $14 | $25 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $19 | $19 | $19 | $20 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $19 | $19 | $19 | $20 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $33 | $34 | $33 | $45 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $0 | $0 |
| Short-Term Debt | $0 | $0 | $0 | $14 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $6 | $4 | $3 | $3 |
| Total Curr. Liab. | $6 | $6 | $4 | $18 |
| LT Debt | $33 | $32 | $32 | $31 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $33 | $32 | $32 | $31 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $40 | $38 | $36 | $49 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$506 | -$497 | -$491 | -$486 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $499 | $493 | $488 | $482 |
| Total Equity | -$7 | -$4 | -$3 | -$4 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $33 | $34 | $33 | $45 |
| Net Debt | $23 | $20 | $19 | $21 |